140 related articles for article (PubMed ID: 35236807)
1. Importance to Know the Long-Term Outcome after Endovascular Therapy with Bare Metal Stent Implantation for Femoropopliteal Artery Disease.
Ito N
J Atheroscler Thromb; 2022 Oct; 29(10):1423-1424. PubMed ID: 35236807
[No Abstract] [Full Text] [Related]
2. The endovascular approach for in-stent restenosis in femoropopliteal disease.
Cannavale A; Tsetis D; Krokidis M
Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):391-401. PubMed ID: 25761905
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Drug-Eluting Stent with Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
Ding Y; Zhou M; Wang Y; Cai L; Shi Z
Ann Vasc Surg; 2018 Jul; 50():96-105. PubMed ID: 29514049
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
6. Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass.
Schneider PA; Krievins DK; Halena G; Schmidt A; Lyden S; Lee V; Hu M; Adelman M
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1266-1272.e3. PubMed ID: 33429092
[TBL] [Abstract][Full Text] [Related]
7. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease.
Haine A; Schmid MJ; Schindewolf M; Lenz A; Bernhard SM; Drexel H; Baumgartner I; Dopheide JF
Eur J Vasc Endovasc Surg; 2019 Dec; 58(6):865-873. PubMed ID: 31668949
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis Comparing Endovascular Treatment Modalities for Femoropopliteal Peripheral Artery Disease.
Khan MS; Zou F; Khan AR; Moustafa A; Schmid CH; Baig M; Hyder ON; Aronow HD
Am J Cardiol; 2020 Aug; 128():181-188. PubMed ID: 32650917
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of the heparin-bonded Viabahn stent graft in femoropopliteal TASC C and D lesions with a covered stent length of minimum 25 cm.
Uhl C; Dadras A; Reichmann F; Betz T; Zorger N; Toepel I; Steinbauer M
Vascular; 2019 Oct; 27(5):553-559. PubMed ID: 30917750
[No Abstract] [Full Text] [Related]
10. [Endovascular treatment of femoropopliteal arterial occlusive disease].
Kerzmann A; Boesmans E; Holemans C; Quaniers J; Alexandrescu V; Defraigne JO
Rev Med Liege; 2020 Nov; 75(11):717-723. PubMed ID: 33155445
[TBL] [Abstract][Full Text] [Related]
11. [Early experience with self-expanding flexible stent for the treatment of atherosclerotic diseases in the popliteal artery].
Takács T; Mihalovits G; Váradi R; Palásthy Z
Orv Hetil; 2020 Apr; 161(15):588-593. PubMed ID: 32323935
[TBL] [Abstract][Full Text] [Related]
12. Emerging and Future Therapeutic Options for Femoropopliteal and Infrapopliteal Endovascular Intervention.
Kokkinidis DG; Armstrong EJ
Interv Cardiol Clin; 2017 Apr; 6(2):279-295. PubMed ID: 28257775
[TBL] [Abstract][Full Text] [Related]
13. Demystifying the Use of Self-Expandable Interwoven Nitinol Stents in Femoropopliteal Peripheral Arterial Disease.
Peker A; Balendran B; Paraskevopoulos I; Krokidis M
Ann Vasc Surg; 2019 Aug; 59():285-292. PubMed ID: 31009734
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.
Jeon-Slaughter H; Khalili H; Tsai S; Armstrong EJ; Shammas NW; Jawaid O; Lu H; Addo T; Gigliotti O; Abu-Fadel M; Banerjee S
J Invasive Cardiol; 2018 Oct; 30(10):373-379. PubMed ID: 30279293
[TBL] [Abstract][Full Text] [Related]
15. Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist's Perspective.
Shammas NW; Banerjee S
J Invasive Cardiol; 2015 Nov; 27(11):E258-61. PubMed ID: 26524213
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
17. Untangling the knot of the best endovascular treatment for femoropopliteal artery disease.
Giacoppo D
Int J Cardiol; 2024 Jul; 407():132108. PubMed ID: 38692491
[No Abstract] [Full Text] [Related]
18. [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia].
Steiner S; Schmidt A; Scheinert D
Internist (Berl); 2019 Feb; 60(2):149-160. PubMed ID: 30683968
[TBL] [Abstract][Full Text] [Related]
19. Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?
Treitl KM; Woerner B; Schinner R; Czihal M; Notohamiprodjo S; Hoffmann U; Treitl M
Eur Radiol; 2017 Sep; 27(9):3947-3955. PubMed ID: 28168366
[TBL] [Abstract][Full Text] [Related]
20. Discussion.
J Vasc Surg; 2015 Jun; 61(6):1488. PubMed ID: 26004326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
